Spotlight

what_clinicians_should_know_spotlight

FDA approves first biosimilar Zarxio™ (filgrastim-sndz) from Sandoz.

Sandoz is the first company to receive approval of a biosimilar in the US.

Follow us

f_logo.jpg logo_youtube.jpg logo_twitter.jpg linkedin_internet.jpg

Healthcare Professionals

Portlet_HCPs

Biosimilar medicines offer physicians more choices at affordable prices thereby increasing patient access without increasing overall spending.

Payors

Portlet_Payers.jpg

Bending the curve of rising healthcare costs without compromising access to quality medical care for its citizens remains one of the most daunting challenges that governments are faced with.

Slideshow Background Images